Jefferies Group LLC Analysts Give Stericycle, Inc. (SRCL) a $108.00 Price Target

Stericycle, Inc. (NASDAQ:SRCL) has been given a $108.00 price objective by Jefferies Group LLC in a report released on Tuesday. The firm currently has a “buy” rating on the business services provider’s stock. Jefferies Group LLC’s price target suggests a potential upside of 51.54% from the stock’s current price. Jefferies Group also issued estimates for Stericycle’s Q3 2017 earnings at $1.13 EPS, Q4 2017 earnings at $1.22 EPS, FY2017 earnings at $4.59 EPS and FY2018 earnings at $4.80 EPS.

A number of other analysts have also recently weighed in on SRCL. BMO Capital Markets started coverage on shares of Stericycle in a report on Thursday, June 29th. They set a “market perform” rating and a $81.00 price objective on the stock. Zacks Investment Research raised shares of Stericycle from a “hold” rating to a “buy” rating and set a $85.00 price objective on the stock in a report on Wednesday, July 5th. BidaskClub raised shares of Stericycle from a “strong sell” rating to a “sell” rating in a report on Monday, July 24th. Barclays PLC reissued an “overweight” rating and set a $100.00 price objective on shares of Stericycle in a report on Wednesday, August 9th. Finally, William Blair reissued an “ourperform” rating on shares of Stericycle in a report on Thursday, September 14th. Four equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and six have given a buy rating to the stock. Stericycle currently has an average rating of “Hold” and an average target price of $81.25.

Shares of Stericycle (SRCL) opened at 71.27 on Tuesday. The stock’s market cap is $6.08 billion. Stericycle has a 52-week low of $68.62 and a 52-week high of $88.00. The firm’s 50-day moving average is $71.20 and its 200 day moving average is $77.45.

Stericycle (NASDAQ:SRCL) last released its quarterly earnings data on Thursday, August 3rd. The business services provider reported $1.15 earnings per share for the quarter, topping analysts’ consensus estimates of $1.13 by $0.02. Stericycle had a negative net margin of 0.07% and a positive return on equity of 14.35%. The company had revenue of $917.70 million for the quarter, compared to analysts’ expectations of $902.81 million. During the same quarter last year, the company earned $1.18 earnings per share. The firm’s revenue for the quarter was up 2.9% on a year-over-year basis. Analysts forecast that Stericycle will post $4.59 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece was originally reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this piece on another site, it was illegally stolen and republished in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://ledgergazette.com/2017/10/18/jefferies-group-llc-analysts-give-stericycle-inc-srcl-a-108-00-price-target.html.

Institutional investors have recently made changes to their positions in the company. Kernodle & Katon Asset Management Group LLC acquired a new position in shares of Stericycle in the 1st quarter valued at $100,000. Invictus RG acquired a new position in shares of Stericycle in the 1st quarter valued at $145,000. Pacer Advisors Inc. increased its holdings in shares of Stericycle by 8.4% in the 2nd quarter. Pacer Advisors Inc. now owns 1,880 shares of the business services provider’s stock valued at $143,000 after acquiring an additional 145 shares during the period. Smith Shellnut Wilson LLC ADV acquired a new position in shares of Stericycle in the 2nd quarter valued at $223,000. Finally, Benjamin F. Edwards & Company Inc. incre

A number of other analysts have also recently weighed in on SRCL. BMO Capital Markets started coverage on shares of Stericycle in a report on Thursday, June 29th. They set a “market perform” rating and a $81.00 price objective on the stock. Zacks Investment Research raised shares of Stericycle from a “hold” rating to a “buy” rating and set a $85.00 price objective on the stock in a report on Wednesday, July 5th. BidaskClub raised shares of Stericycle from a “strong sell” rating to a “sell” rating in a report on Monday, July 24th. Barclays PLC reissued an “overweight” rating and set a $100.00 price objective on shares of Stericycle in a report on Wednesday, August 9th. Finally, William Blair reissued an “ourperform” rating on shares of Stericycle in a report on Thursday, September 14th. Four equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and six have given a buy rating to the stock. Stericycle currently has an average rating of “Hold” and an average target price of $81.25.

Shares of Stericycle (SRCL) opened at 71.27 on Tuesday. The stock’s market cap is $6.08 billion. Stericycle has a 52-week low of $68.62 and a 52-week high of $88.00. The firm’s 50-day moving average is $71.20 and its 200 day moving average is $77.45.

Stericycle (NASDAQ:SRCL) last released its quarterly earnings data on Thursday, August 3rd. The business services provider reported $1.15 earnings per share for the quarter, topping analysts’ consensus estimates of $1.13 by $0.02. Stericycle had a negative net margin of 0.07% and a positive return on equity of 14.35%. The company had revenue of $917.70 million for the quarter, compared to analysts’ expectations of $902.81 million. During the same quarter last year, the company earned $1.18 earnings per share. The firm’s revenue for the quarter was up 2.9% on a year-over-year basis. Analysts forecast that Stericycle will post $4.59 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece was originally reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this piece on another site, it was illegally stolen and republished in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://ledgergazette.com/2017/10/18/jefferies-group-llc-analysts-give-stericycle-inc-srcl-a-108-00-price-target.html.

Institutional investors have recently made changes to their positions in the company. Kernodle & Katon Asset Management Group LLC acquired a new position in shares of Stericycle in the 1st quarter valued at $100,000. Invictus RG acquired a new position in shares of Stericycle in the 1st quarter valued at $145,000. Pacer Advisors Inc. increased its holdings in shares of Stericycle by 8.4% in the 2nd quarter. Pacer Advisors Inc. now owns 1,880 shares of the business services provider’s stock valued at $143,000 after acquiring an additional 145 shares during the period. Smith Shellnut Wilson LLC ADV acquired a new position in shares of Stericycle in the 2nd quarter valued at $223,000. Finally, Benjamin F. Edwards & Company Inc. increased its holdings in shares of Stericycle by 8.5% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 2,540 shares of the business services provider’s stock valued at $194,000 after acquiring an additional 200 shares during the period. 93.54% of the stock is currently owned by institutional investors and hedge funds.

About Stericycle

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply